GME
GameStop Corp.
GME's fundamentals are strong: its operating margin rose 11 points to 14% and it turned 19% of its revenue into free cash flow, though revenue fell 7.7%. At 17x earnings, it's trading less than half its usual 44x. Analysts expect earnings to fall sharply.
MRM
MEDIROM Healthcare Technologies Inc.
There isn't enough reported data to score MRM yet.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
MRM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate MRM's fundamentals.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME's PE is in its cheap range at 17x. Analysts expect earnings to fall, which would put today's price at 38x next year's earnings, in its fair range.
MRM PE Valuation
MRM has no meaningful PE right now: it lost money over the past year.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
MRM Forward outlook
There aren't enough analyst estimates for MRM to show an outlook.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME's earnings per share have climbed steadily: $1.54 over the past year, up 93% from the year before, and higher year over year for 15 quarters in a row.
MRM Earnings Per Share
MRM and GME do not have enough comparable growth data to identify a winner.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME has the edge over MRM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME's operating margin was 20% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2019.
MRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $3.8M | -87% |
| Q2 2025 | $20.3M | -6.7% |
| Q4 2024 | $30.2M | +35% |
| Q2 2024 | $21.8M | +7.2% |
| Q4 2023 | $22.5M | -5.8% |
| Q2 2023 | $20.3M | +106% |
| Q4 2022 | $23.9M | +132% |
| Q2 2022 | $9.9M | -26% |
MRM's revenue has held roughly level: $4M last quarter, down 83% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 12% | +14 points |
| Q2 2025 | -28% | -19 points |
| Q4 2024 | 13% | +6.2 points |
| Q2 2024 | -18% | -13 points |
| Q4 2023 | -2.3% | +12 points |
| Q2 2023 | -9.6% | +15 points |
| Q4 2022 | 6.6% | +60 points |
| Q2 2022 | -4.9% | +59 points |
MRM's operating margin was 12% last quarter, up 14 points from the same quarter a year ago.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME generated $688M in free cash flow over the past year, up 43% from the year before.
MRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$2.3M | +$2.7M |
| Q4 2024 | -$6.8M | -$6.2M |
| Q2 2024 | -$5M | -$865.8K |
| Q4 2023 | -$634.9K | +$2.4M |
| Q2 2023 | -$4.2M | -$3.2M |
| Q4 2022 | -$3M | -$2.2M |
| Q2 2022 | -$1M | +$197.1K |
| Q4 2021 | -$825K | -4728% |
MRM has burned cash in most quarters: −$15M over the past year, against −$9M the year before.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has the edge over MRM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
MRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +3K shares |
| 1 year | +45% | +2.5M shares |
| 3 years | +85% | +3.6M shares |
MRM has 8M diluted shares, up 45% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q2 2023 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
GME Net Leverage
MRM Net Leverage
MRM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
MRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.1 | Oversold |
| Stochastic | 6.2 | Oversold |
MRM's weekly RSI is 22 (oversold) and its Stochastic is 6 (oversold).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
MRM PE vs Consumer Cyclical Sector
| Metric | MRM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MRM has no meaningful PE right now: it lost money over the past year.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over MRM on trend strength, trading above more of its moving averages.
MRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.43 | 35% below |
| 20 week MA | $0.74 | 62% below |
| 50 week MA | $1.15 | 76% below |
| 100 week MA | $1.28 | 78% below |
| 200 week MA | $3.21 | 91% below |
MRM is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over MRM on returns for 2026, with the stronger performance.
MRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $14.4 | $6.26 | -57% |
| 2022 | $6.26 | $5.58 | -11% |
| 2023 | $5.58 | $5.72 | +2.5% |
| 2024 | $5.72 | $1.05 | -82% |
| 2025 | $1.05 | $2.21 | +110% |
| 2026 YTD | $2.21 | $0.28 | -87% |
MRM's yearly returns have swung widely, from +110% in 2025 to −82% in 2024. It's down 87% so far in 2026.